DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System Inhibition-Reference-Cited by-同舟云学术

DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System Inhibition

Published:2018-09 Issue:3 Volume:72 Page:712-719
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Hubers Scott A.¹²,Wilson Jessica R.¹³,Yu Chang⁴,Nian Hui⁴,Grouzmann Eric⁵,Eugster Philippe⁵,Shibao Cyndya A.¹,Billings Frederic T.⁶,Jafarian Kerman Scott¹,Brown Nancy J.¹

Affiliation:

1. From the Division of Clinical Pharmacology, Department of Medicine (S.A.H., J.R.W., C.A.S., S.J.K., N.J.B.)

2. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (S.A.H.)

3. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Pennsylvania, Philadelphia (J.R.W.)

4. Department of Biostatistics (C.Y., H.N.)

5. Service de Pharmacologie Clinique, Laboratoire des Catécholamines et Peptides, University Hospital of Lausanne, Switzerland (E.G., P.E.).

6. Department of Anesthesiology (F.T.B.), Vanderbilt University Medical Center, Nashville, TN

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference27 articles.

1. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides

2. Incretin-based therapies for type 2 diabetes mellitus

3. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.;Michel MC;Pharmacol Rev,1998

4. EFFECTS OF DIPEPTIDYL PEPTIDASE IV INHIBITION ON ARTERIAL BLOOD PRESSURE

5. Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic Hypertension

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicotine and Neurotransmitters an Update;Research Journal of Pharmacy and Technology;2024-06-25

2. Structural basis of neuropeptide Y signaling through Y₁ and Y₂ receptors;MedComm;2024-06-15

3. Neuropeptide Y: Direct vasoconstrictor and facilitatory effects on P2X1 receptor-dependent vasoconstriction in human small abdominal arteries;Vascular Pharmacology;2023-08

4. Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1;Cell Reports;2023-02

5. Effects of DPP-4 inhibitors on brain natriuretic peptide, neuropeptide Y, glucagon like peptide-1, substance P levels and global longitudinal strain measurements in type 2 diabetes mellitus patients;Journal of Health Sciences and Medicine;2022-09-25